ANNA HASELEY: Open Payments
NPI 1851879696 · ORCHARD PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$982 in 48 payments from 15 companies in 2025. Trend: 2023 $100 · 2024 $1,090 · 2025 $982
Food & beverage: $982
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 5 | $194 |
| Merck Sharp & Dohme LLC | 7 | $147 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $138 |
| AstraZeneca Pharmaceuticals LP | 5 | $104 |
| E.R. Squibb & Sons, L.L.C. | 5 | $88 |
| Novo Nordisk Inc | 5 | $82 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
| Edwards Lifesciences Corporation | 1 | $40 |
| SCPHARMACEUTICALS INC. | 2 | $38 |
| HEARTFLOW, INC. | 1 | $23 |
Products named: JARDIANCE, AMVUTTRA, VERQUVO, Wegovy, CAMZYOS, ONPATTRO, WAINUA, FARXIGA.
Industry payments across NY — which companies pay providers there.
